H-1B Filings
55
Major sponsor. DOL labor condition applications on file.
GlaxoSmithKline LLC in PA (Manufacturing) shows all three federal tracks on this profile: 55 H-1B LCAs, an employer OSHA injury record, and 1 WARN notice.
GlaxoSmithKline LLC (PA): · 55 H-1B LCAs at a $146,008 disclosed median · OSHA Grade A (DART 0.30) · 1 WARN notice
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, GlaxoSmithKline LLC in PA carries 55 H-1B wage filings on record, a $146,008 median wage across 52 disclosed-wage positions (above the $124,488 national median), a strong A OSHA safety grade and 1 WARN layoff notice on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
Layoff & federal record
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #866 of 51,370 sponsors in this corpus (about the 98th percentile), and disclosed median wage sits at the 66th percentile of 272,125 credible H-1B wage rows.
Figures above come from DOL H-1B LCAs, this employer's OSHA injury log, and state WARN notices, three independent disclosure systems.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
DOL LCA release change
H-1B Filings
55
Major sponsor. DOL labor condition applications on file.
Median H-1B Salary
$146,008
Above national median. Across 52 disclosed positions
OSHA Safety Grade
Grade A · DART 0.30
Safer than industry average. vs 1.14 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
WARN Workforce Impact
150 workers
Less stable than most peers. 1 WARN Act notice on file
Where GlaxoSmithKline LLC's H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$146,008 Top 34% higher than 66% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Filing-count-weighted median across this employer's own disclosed H-1B positions (-4% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
| Field | Value | Source |
|---|---|---|
| Employer Name | GlaxoSmithKline LLC | DOL OFLC / OSHA / WARN |
| Industry | Manufacturing | NAICS / DOL |
| State | PA | U.S. Federal Records |
| H-1B Filings | 55 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $146,008 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | A | OSHA ITA |
| OSHA DART Rate | 0.30 | OSHA ITA Establishment Records |
| WARN Layoff Notices | 1 notice(s), 150 workers | WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com) |
GlaxoSmithKline LLC's values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records, WARN Act notices on file for this employer in PA (Manufacturing). In this corpus, H-1B filing volume ranks #866 of 51,370 sponsors in this corpus (about the 98th percentile); disclosed median wage sits at the 66th percentile of 272,125 credible H-1B wage rows; OSHA DART rate is safer than roughly 61% of 214,554 employers with an establishment injury record.
| Job Title | Median |
|---|---|
| Executive Director Precision Medicine Portfolio Planning | $273,700 |
| Engineering Director | $213,000 |
| Senior Director of Engineering | $205,700 |
| Software Engineer - AI/ML Services | $205,379 |
| Product Director, Platform API | $199,000 |
| Director – Omnichannel BU Analytics Lead | $197,000 |
| Senior Data Engineer | $190,957 |
| Associate Director - Global Regulatory Affairs, Oncology | $189,022 |
| Senior Platform Engineer - Governance | $182,312 |
| Director - Quantitative Systems Pharmacology | $180,750 |
| Sr Manager - Oncology Commercial Analytics, Multiple Myeloma | $180,500 |
| Principal Software Engineer - DevOps | $179,000 |
| Associate Director – Genomic Technologies | $178,000 |
| Associate Director, Modeller | $178,000 |
| Principal Scientist, Biologic AI Research and Design | $173,500 |
| Senior Application Engineer | $172,744 |
| Statistics Leader | $170,000 |
| Scientific Director, Immunoassays | $161,857 |
| Senior Product Manager - Compute Platform | $159,885 |
| Assoc. Director, Machine Learning Developer & Data Scientist | $158,000 |
| Manager Business Analytics | $153,733 |
| Manager Business Analytics | $153,733 |
| Quality R&D Operations Drug Product Director | $152,574 |
| Manager Medical Analytics Insights | $151,523 |
| Cloud Engineer II | $147,846 |
| Sr. Principal Scientist | $146,008 |
| Specialty Analytics Manager | $145,687 |
| Product Manager II Target Discovery | $143,000 |
| Principal Tech Product Owner: Oncology Development | $142,771 |
| Investigator | $142,120 |
| Associate Director and Group Leader, LC-MS BESM | $141,083 |
| Principal Scientist, Discovery DMPK Bioanalytical | $140,000 |
| Digital Marketing Tech, Senior Architect | $138,570 |
| Sr Manager - Oncology Commercial Analytics, Multiple Myeloma | $136,323 |
| Associate Director - Genomic Technologies, HGG | $133,500 |
| Principal Scientist | $130,000 |
| Clinical Research Statistician | $127,965 |
| Product Owner, Planisware | $123,072 |
| Investigator - Biomarkers, Oncology | $122,853 |
| Investigator, Modeling & Simulation | $120,411 |
| Forecasting Manager | $119,250 |
| Assistant General Counsel, Legal “ Business Development | $117,645 |
| Scientific Investigator | $111,350 |
| Scientific Investigator | $111,350 |
| Scientific Investigator - Genome Biology, TD | $111,350 |
| Scientific Investigator - Omics Sciences, TD | $110,424 |
| Investigator, Modeling and Simulation | $110,250 |
| Principal Scientist, Discovery Bioanalysis | $109,616 |
| Principal Scientist, Discovery DMPK Bioanalyst, US | $109,616 |
| Programmer Analyst | $105,494 |
GlaxoSmithKline LLC's most extreme placement is sponsorship scale: 55 H-1B LCAs rank higher than 98% of sponsors in this corpus (#866 of 51,370).
1 WARN notice naming about 150 workers are on file in PA. Multiple notices can reflect consolidations — read them beside sponsorship and safety signals.
OSHA logged 15 injuries at a DART rate of 0.3 against a 1.1 same-NAICS-sector average (Grade A).
FY2025 filings fell 36.4% from FY2024 (22 → 14).
GlaxoSmithKline LLC is one of the rarer profiles carrying both sponsorship volume (55 H-1B LCAs) and WARN history (1 notice) in the same public record (Manufacturing) in PA. Weigh those signals separately.
A $146,008 disclosed median lands near the middle of the wage distribution (66th percentile vs $124,488 nationally).
GlaxoSmithKline LLC's DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Manufacturing).
Total reported injuries on file: 15.
Where GlaxoSmithKline LLC sits
Across the 200 Manufacturing sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, GlaxoSmithKline LLC files more petitions than 66% of them and discloses a higher median wage than 59%, the high-volume, above-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (55 filings · $146,008 median here).
Each muted dot is one manufacturing peer from a filings-stratified sample of 41; the brand marker is GlaxoSmithKline LLC. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
GlaxoSmithKline LLC's nearest H-1B-filing peers in Manufacturing (home state PA). Each card links to that employer's federal-records profile.
Two federal-records peer sets for GlaxoSmithKline LLC, both outside PA so the neighborhoods are not the same-industry VsCard above.
Nearest injury-rate peers outside PA (DART 0.30 here).
Peers are nearest-neighbor matches on disclosed filing counts and OSHA ITA DART rates; employers with fewer than 100 H-1B filings or fewer than 10 reported injuries are excluded from the comparison corpus.
| Notice Date | Workers |
|---|---|
| 2015-02-01 | 150 |
What to check before working with GlaxoSmithKline LLC
GlaxoSmithKline LLC needs a three-way read: H-1B pay (55 LCAs), safety (grade A), and WARN history (1 notice); none of those alone is the rating.
GlaxoSmithKline LLC's figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Among 272,125 credible H-1B wage rows in this corpus, GlaxoSmithKline LLC's disclosed median of $146,008 sits at the 66th percentile (above the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
GlaxoSmithKline LLC has 55 H-1B filings on record, ranking #866 of 51,370 sponsors in this corpus (about the 98th percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
GlaxoSmithKline LLC carries Grade A from its establishment injury record (15 injuries on file; DART 0.30). That DART rate is safer than roughly 61% of 214,554 employers with an injury record in this corpus. Grades compare DART against industry averages, see the Interpreting Safety Grades guide.
Yes - 1 WARN Act notice affecting about 150 workers appear in the state-agency corpus for this employer. WARN covers mass layoffs and plant closings that meet statutory thresholds; absence of notices is not a guarantee of stability.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings, OSHA Injury Tracking Application records and state WARN Act layoff notices, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.